Constulose
Constulose is an FDA drug label for the active ingredient LACTULOSE manufactured by Actavis Pharma, Inc. administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20220601.
- Generic name
- LACTULOSE
- Manufacturer
- Actavis Pharma, Inc.
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- ORAL
- Dosage form
- N/A
- NDC
- 45963-439
- Application
- ANDA090503
- Label effective
- 20220601
About this product
Constulose is an FDA-registered drug product whose active ingredient is LACTULOSE. It is labelled by Actavis Pharma, Inc. taken by oral and marketed as a human prescription drug product. Identifiers on file: NDC 45963-439, application ANDA090503, label effective 20220601. It is one of 9 FDA drug label records sharing the active ingredient LACTULOSE. This page reproduces the FDA-approved label text so you can check what a product is, who makes it and how it is supplied before discussing it with a pharmacist or prescriber.
What it is used for
Across FDA labelling, products containing LACTULOSE are most often described in connection with: bowel movements, treatment constipation, history chronic, lactulose solution, therapy increases, number days. Wording differs between labels, and the full indications section on this page takes precedence when it is present.
Indications & Usage
INDICATIONS AND USAGE For the treatment of constipation. In patients with a history of chronic constipation, lactulose solution therapy increases the number of bowel movements per day and the number of days on which bowel movements occur.
Dosage & Administration
DOSAGE AND ADMINISTRATION The usual dose is 1 to 2 tablespoonfuls (15 to 30 mL, containing 10 g to 20 g of lactulose) daily. The dose may be increased to 60 mL daily if necessary. Twenty-four to 48 hours may be required to produce a normal bowel movement. Note: Some patients have found that lactulose solution may be more acceptable when mixed with fruit juice, water or milk.
Contraindications
CONTRAINDICATIONS Since lactulose solution contains galactose (less than 1.6 g/15 mL), it is contraindicated in patients who require a low galactose diet.
Warnings
WARNINGS A theoretical hazard may exist for patients being treated with lactulose solution who may be required to undergo electrocautery procedures during proctoscopy or colonoscopy. Accumulation of H 2 gas in significant concentration in the presence of an electrical spark may result in an explosive reaction. Although this complication has not been reported with lactulose, patients on lactulose therapy undergoing such procedures should have a thorough bowel cleansing with a non-fermentable solution. Insufflation of CO 2 as an additional safeguard may be pursued but is considered to be a redundant measure.
Adverse Reactions
ADVERSE REACTIONS Precise frequency data are not available. Initial dosing may produce flatulence and intestinal cramps, which are usually transient. Excessive dosage can lead to diarrhea with potential complications such as loss of fluids, hypokalemia, and hypernatremia. Nausea and vomiting have been reported. To report SUSPECTED ADVERSE EVENTS, contact the FDA at 1-800-FDA-1088 or http://www.fda.gov/ for voluntary reporting of adverse reactions.
More products with the same ingredient
LACTULOSEEnulose
View labelKRISTALOSE
View labelLACTULOSE
View labelLACTULOSE
View labelLactulose
View labelLactulose
View labelLactulose
View labelHow products containing LACTULOSE compare
FDA lists 9 drug label records with LACTULOSE as the active ingredient. The most common dosage forms and the manufacturers with the most records are summarised below; strengths, pack sizes and inactive ingredients can still differ between apparently similar products.
| Dosage form | Products | Manufacturer | Products |
|---|---|---|---|
| — | — | Actavis Pharma, Inc. | 2 |
| — | — | APOZEAL PHARMACEUTICALS INC | 1 |
| — | — | Cardinal Health 107, LLC | 1 |
| — | — | Cumberland Pharmaceuticals Inc. | 1 |
| — | — | Fresenius Kabi Austria GmbH | 1 |
Frequently asked questions
What is Constulose used for?
INDICATIONS AND USAGE For the treatment of constipation. In patients with a history of chronic constipation, lactulose solution therapy increases the number of bowel movements per day and the number of days on which bowel movements occur.
Who makes Constulose?
Actavis Pharma, Inc. is the labeler of record for Constulose. 9 FDA label records share the active ingredient LACTULOSE, so generic and branded versions may come from different companies; the manufacturer named on your pack is the one that matters for any enquiry.
What form does Constulose come in?
administered by oral. Strengths and pack sizes vary by label, so compare the NDC on your pack with the identifier listed on this page.
Is Constulose prescription or over-the-counter?
The FDA label for this product is recorded as human prescription drug. Marketing status can differ between strengths and countries, so check the dispensing rules where you live.
Are there other products containing LACTULOSE?
Yes. 9 FDA drug label records list LACTULOSE as the active ingredient. Products with the same active ingredient can usually be substituted only when a prescriber or pharmacist confirms it is appropriate.
Has Constulose been recalled?
No FDA recall record in our database matches this product name or manufacturer. Recall data is updated periodically, so a very recent notice may not appear here yet.
Where does this information come from?
All content is reproduced from FDA Structured Product Labelling data via openFDA. It is provided for identification and reference only and is not medical advice.
This page reproduces FDA Structured Product Labelling data for identification and reference. It is not medical advice, does not diagnose or treat any condition, and does not sell or price any medicine.